{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:59:38Z","timestamp":1787065178774,"version":"build-2736575974"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>There are limited prospective data on whether established risk factors modify breast cancer risk in women with pathogenic variants (PV) in BRCA1\/2 and virtually no risk modification data for ATM, CHEK2, or PALB2. We conducted a nested case\u2013control study in the Women\u2019s Health Initiative (WHI), randomly selecting women with and without breast cancer for DNA sequencing. We evaluated breast cancer odds associated with obesity, family cancer history, smoking, alcohol, parity, breastfeeding, oophorectomy, tubal ligation, neighborhood socioeconomic status, and menopausal hormone therapy (MHT) with estrogen and progestin or estrogen only in PV carriers and noncarriers. In exploratory analyses, we grouped genes by established predisposition for estrogen receptor (ER)-positive (ATM and CHEK2) or ER-negative (BRCA1 and PALB2) disease. Multivariable models with interaction terms were used to assess differential risk modification by PVs. Among 12,957 WHI participants, 287 carried PVs. Breastfeeding was modestly associated with reduced risk for PALB2 [OR = 0.08; 95% confidence interval (CI), 0.00\u20130.92; P value = 0.042]. With one-sided 95% CI, power was sufficient to exclude OR \u22652.0 with obesity for ATM and BRCA2; smoking and alcohol for CHEK2; no breastfeeding for ATM; no oophorectomy for BRCA2 and CHEK2; no tubal ligation for CHEK2; and neighborhood socioeconomic status for all genes. Estrogen + progestin MHT was modestly associated with increased risk for ER-positive PVs (OR = 7.31; 95% CI, 1.14\u201364.20; P = 0.036). PVs did not modify risk (interaction P \u2265 0.05). BRCA1\/2, ATM, CHEK2, and PALB2 PV carriers do not have breast cancer OR \u22652.0 with many established risk factors. However, MHT warrants additional study in PV carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>There is limited information on whether established risk factors increase breast cancer risk from PVs. In the WHI, PV carriers had no substantial (\u22652-fold) increase with most risk factors, except potentially MHT in ATM or CHEK2 carriers. The results may inform counseling and research on MHT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0592","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:32:09Z","timestamp":1745911929000},"page":"783-791","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Breast Cancer Risk Modification in Women with Pathogenic Variants in\n                    <i>BRCA1<\/i>\n                    ,\n                    <i>BRCA2<\/i>\n                    ,\n                    <i>ATM<\/i>\n                    ,\n                    <i>CHEK2<\/i>\n                    , and\n                    <i>PALB2<\/i>"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-9470","authenticated-orcid":false,"given":"Allison W.","family":"Kurian","sequence":"first","affiliation":[{"name":"1Department of Medicine, Stanford University School of Medicine, Stanford, California."},{"name":"2Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-3913","authenticated-orcid":false,"given":"Elisha","family":"Hughes","sequence":"additional","affiliation":[{"name":"3Myriad Genetics, Salt Lake City, Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-6929","authenticated-orcid":false,"given":"Ryan","family":"Bernhisel","sequence":"additional","affiliation":[{"name":"3Myriad Genetics, Salt Lake City, Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5247-4136","authenticated-orcid":false,"given":"Eudora","family":"Hu","sequence":"additional","affiliation":[{"name":"3Myriad Genetics, Salt Lake City, Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5152-8740","authenticated-orcid":false,"given":"Eric C.","family":"Polley","sequence":"additional","affiliation":[{"name":"4Department of Public Health Services, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-9903","authenticated-orcid":false,"given":"Siddhartha","family":"Yadav","sequence":"additional","affiliation":[{"name":"5Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-4639","authenticated-orcid":false,"given":"Chunling","family":"Hu","sequence":"additional","affiliation":[{"name":"5Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5711-8355","authenticated-orcid":false,"given":"Jennifer L.","family":"Caswell-Jin","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-8003","authenticated-orcid":false,"given":"Esther M.","family":"John","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Stanford University School of Medicine, Stanford, California."},{"name":"2Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-0522","authenticated-orcid":false,"given":"Aladdin H.","family":"Shadyab","sequence":"additional","affiliation":[{"name":"6Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-6184","authenticated-orcid":false,"given":"Rowan","family":"Chlebowski","sequence":"additional","affiliation":[{"name":"7The Lundquist Institute, Torrance, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-7851","authenticated-orcid":false,"given":"Rami","family":"Nassir","sequence":"additional","affiliation":[{"name":"8Department of Pathology, School of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-8103","authenticated-orcid":false,"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[{"name":"9National Cancer Institute, NIH, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-6996","authenticated-orcid":false,"given":"Marcia L.","family":"Stefanick","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-9985","authenticated-orcid":false,"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[{"name":"5Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2026031614485251200_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-society of surgical oncology guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026031614485251200_bib2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.19.02190","article-title":"Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer","volume":"38","author":"Yadav","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026031614485251200_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026031614485251200_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"key":"2026031614485251200_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2020.0229","article-title":"Prevalence of pathogenic variants in cancer susceptibility genes among women with postmenopausal breast cancer","volume":"323","author":"Kurian","year":"2020","journal-title":"JAMA"},{"key":"2026031614485251200_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/humupd\/dmac038","article-title":"Contraceptives and cancer risks in BRCA1\/2 pathogenic variant carriers: a systematic review and meta-analysis","volume":"29","author":"van Bommel","year":"2023","journal-title":"Hum Reprod Update"},{"key":"2026031614485251200_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-023-01636-1","article-title":"Modifiable risk factors in women at high risk of breast cancer: a systematic review","volume":"25","author":"Cohen","year":"2023","journal-title":"Breast Cancer Res"},{"key":"2026031614485251200_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13058-023-01673-w","article-title":"Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium","volume":"25","author":"Kast","year":"2023","journal-title":"Breast Cancer Res"},{"key":"2026031614485251200_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1055-9965.EPI-24-0743","article-title":"Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years","volume":"34","author":"Kehm","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026031614485251200_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/jnci\/djaa031","article-title":"Radiation treatment, ATM, BRCA1\/2, and CHEK2*1100delC pathogenic variants and risk of contralateral breast cancer","volume":"112","author":"Reiner","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2026031614485251200_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jnci\/djy132","article-title":"Height and body mass index as modifiers of breast cancer risk in BRCA1\/2 mutation carriers: a mendelian randomization study","volume":"111","author":"Qian","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2026031614485251200_bib12","doi-asserted-by":"crossref","first-page":"pky023","DOI":"10.1093\/jncics\/pky023","article-title":"Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study","volume":"2","author":"Schrijver","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"2026031614485251200_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ije\/dyy039","article-title":"Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers","volume":"47","author":"Kim","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2026031614485251200_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00404-017-4546-y","article-title":"Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis","volume":"296","author":"Grill","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2026031614485251200_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-016-3685-3","article-title":"Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study","volume":"155","author":"Kotsopoulos","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2026031614485251200_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-015-3393-4","article-title":"Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"151","author":"Cybulski","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2026031614485251200_bib17","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1158\/1055-9965.EPI-08-0396","article-title":"Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1\/2 mutation carriers and noncarriers: results from a population-based study","volume":"17","author":"Lee","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026031614485251200_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/1055-9965.EPI-06-0829","article-title":"Age at menarche and menopause and breast cancer risk in the International BRCA1\/2 Carrier Cohort Study","volume":"16","author":"Chang-Claude","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026031614485251200_bib19","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1055-9965.EPI-06-0258","article-title":"BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50","volume":"15","author":"Haile","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026031614485251200_bib20","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2005.03.3126","article-title":"Effect of chest x-rays on the risk of breast cancer among BRCA1\/2 mutation carriers in the International BRCA1\/2 Carrier Cohort Study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators\u2019 Group","volume":"24","author":"Andrieu","year":"2006","journal-title":"J Clin Oncol"},{"key":"2026031614485251200_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/djj132","article-title":"Pregnancies, breastfeeding and breast cancer risk in the International BRCA1\/2 Carrier Cohort Study (IBCCS)","volume":"98","author":"Andrieu","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 9","key":"2026031614485251200_bib22","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the Women\u2019s Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"Suppl 9","key":"2026031614485251200_bib23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the women\u2019s health initiative study design","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"Suppl 9","key":"2026031614485251200_bib24","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","article-title":"The Women\u2019s Health Initiative recruitment methods and results","volume":"13","author":"Hays","year":"2003","journal-title":"Ann Epidemiol"},{"key":"2026031614485251200_bib25","doi-asserted-by":"crossref","first-page":"101417","DOI":"10.1016\/j.ssmph.2023.101417","article-title":"Quantifying structural racism in cohort studies to advance prospective evidence","volume":"22","author":"Follis","year":"2023","journal-title":"SSM Popul Health"},{"key":"2026031614485251200_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthplace.2012.11.003","article-title":"The relationship between urban sprawl and coronary heart disease in women","volume":"20","author":"Griffin","year":"2013","journal-title":"Health Place"},{"key":"2026031614485251200_bib27","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/bioinformatics\/btu363","article-title":"PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"2026031614485251200_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026031614485251200_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes \u2013 association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"key":"2026031614485251200_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/phn.13504","article-title":"Modifiable risk factors for breast cancer: insights from systematic reviews","volume":"42","author":"Li","year":"2025","journal-title":"Public Health Nurs"},{"key":"2026031614485251200_bib31","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/healthcare11162360","article-title":"Chemoprevention and lifestyle modifications for risk reduction in sporadic and hereditary breast cancer","volume":"11","author":"Manna","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2026031614485251200_bib32","doi-asserted-by":"crossref","first-page":"pky078","DOI":"10.1093\/jncics\/pky078","article-title":"The influence of number and timing of pregnancies on breast cancer risk for women with BRCA1 or BRCA2 mutations","volume":"2","author":"Terry","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"2026031614485251200_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2013.11.004","article-title":"Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies","volume":"38","author":"Pan","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"2026031614485251200_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamaoncol.2021.2040","article-title":"Association of risk-reducing salpingo-oophorectomy with breast cancer risk in women with BRCA1 and BRCA2 pathogenic variants","volume":"7","author":"Choi","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026031614485251200_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026031614485251200_bib36","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"2026031614485251200_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women\u2019s health initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"key":"2026031614485251200_bib38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","journal-title":"Lancet"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0592\/3601661\/crc-24-0592.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/5\/783\/3604175\/crc-24-0592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/5\/783\/3604175\/crc-24-0592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:49:02Z","timestamp":1773686942000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/5\/783\/762299\/Breast-Cancer-Risk-Modification-in-Women-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0592","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29037566","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29037563","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29037575","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29037569","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29037578","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762201","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31762198","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29037572","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7813181","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}